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Abstract
The dietary inflammatory index (DII) is a new tool to assess the inflammatory potential of the diet. In the present study, we aimed to deter-
mine the association between the DII and BMI, waist circumference and waist:height ratio (WHtR). We conducted a cross-sectional study of
7236 participants recruited into the PREvencio´n con DIeta MEDiterra´nea trial. Information from a validated 137-item FFQ was used to
calculate energy, food and nutrient intakes. A fourteen-item dietary screener was used to assess adherence to the Mediterranean diet
(MeDiet). Sex-specific multivariable linear regression models were fitted to estimate differences (and 95 % CI) in BMI, waist circumference
and WHtR across the quintiles of the DII. All nutrient intakes, healthy foods and adherence to the MeDiet were higher in the quintile with
the lowest DII score (more anti-inflammatory values) except for intakes of animal protein, saturated fat and monounsaturated fat. Although
an inverse association between the DII and total energy was apparent, the DII was associated with higher average BMI, waist circumfer-
ence and WHtR after adjusting for known risk factors. The adjusted difference in the WHtR for women and men between the highest and
*Corresponding author: M. Ruiz-Canela, fax: þ34 948 42 56 49, email mcanela@unav.es
Abbreviations: CRP, C-reactive protein; DII, dietary inflammatory index; MeDiet, Mediterranean diet; PREDIMED, PREvencio´n con DIeta MEDiterra´nea;
WHtR, waist:height ratio.
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lowest quintiles of the DII was 1·60 % (95 % CI 0·87, 2·33) and 1·04 % (95 % CI 0·35, 1·74), respectively. Pro-inflammatory scores remained
associated with obesity after controlling for the effect that adherence to a MeDiet had on inflammation. In conclusion, the present
study shows a direct association between the DII and indices of obesity, and supports the hypothesis that diet may have a role in the
development of obesity through inflammatory modulation mechanisms.
Key words: Inflammation: Diet: Obesity: BMI: Waist circumference: Waist:height ratio
The obesity pandemic constitutes a major public health
problem in most high-income countries, and it is emerging
as a threat in more affluent sectors of developing countries(1).
In 2008, more than 10 % of the World’s adult population,
i.e. about 500 million people, were obese according to the
WHO(2). It was estimated that 3·4 million adult deaths world-
wide were, in 2010, attributable to obesity or overweight(1).
This is a global crisis because 65 % of the world’s population
live in countries where overweight and obesity kill more
people than being underweight(2).
Obesity usually is the result of the accumulation of excess
body fat, and it is often characterised as a state of low-grade
chronic inflammation(3). This obesity-induced inflammation has
multi-organ metabolic effects affecting the adipose tissue,
liver, muscle, pancreas and brain(4). Metabolic differences
exist according to the location of fat cells. For example,
excessive deposition of fat in visceral adipose tissue (i.e.
intra-abdominal fat) is associated with higher health risks
than subcutaneous fat accumulation in the extremities(5). In
fact, different anthropometric adiposity measures including
waist circumference or waist:height ratio (WHtR) are used to
assess the role of adiposity in CVD risk(6,7).
A number of studies have shown an association between
diet and inflammatory biomarkers, and how this translates
into increased or decreased risk of chronic metabolic
diseases(8–15). Part of the preventive role of healthy dietary
patterns, such as the Mediterranean diet (MeDiet), could be
attributed to the anti-inflammatory properties of some of their
main components(15–19). This anti-inflammatory effect may
decrease the low-grade inflammation usually found in obese
patients(20,21). However, a MeDiet may also attenuate inflam-
mation in the absence of weight loss(22). A recent hypothesis is
that obesity could also be partly the consequence of a previous
chronic low-grade inflammation; therefore, a bidirectional
association between inflammation and obesity may exist(23).
Consequently, it can be useful to characterise an individual’s
diet according to its inflammatory properties in order to investi-
gate the inflammatory links between obesity and diet(24). The
dietary inflammatory index (DII) is a new tool to assess this
inflammatory potential of the diet(25). In the present study, we
examine the relationships between nutrient intake or food
group consumption and the DII, as well as the association
between theDII and indices of bothgeneral and abdominal obes-
ity in the PREvencio´n con DIeta MEDiterra´nea (PREDIMED) trial.
Methods
Ethics statement
The protocol was approved by the Research Ethics Commit-
tees at all recruiting centres: University of Navarra; University
of Valencia; University Rovira i Virgili; IMIM-Hospital del Mar
Medical Research Institute; University of Barcelona; University
Hospital of Alava; University of Malaga; University of the
Balearic Islands; University of Las Palmas de Gran Canaria;
University Hospital of Bellvitge; Hospital Clinic. Participants
signed a written informed consent form.
Study design and participants
The ‘PREDIMED’ study was a parallel-group, multi-centre,
clinical trial that aimed to assess the effects of the traditional
MeDiet on the primary prevention of CVD (protocol available
at http://www.predimed.es). A detailed description of methods
and patients has been published elsewhere(26,27). The study
was conducted between October 2003 and December 2010
by eleven recruiting centres in Spain.
Eligible participants were men aged 55–80 years and
women aged 60–80 years with no previous CVD. At baseline,
participants should have a diagnosis of type 2 diabetes melli-
tus or at least three of the following major cardiovascular risk
factors: smoking (more than one cigarette per d during the last
month); hypertension (systolic blood pressure $140 mmHg
or diastolic blood pressure $90 mmHg or antihypertensive
medication); elevated LDL-cholesterol levels ($1600 mg/l);
low HDL-cholesterol levels (#400 mg/l in men or #500 mg/l
in women, independently of lipid-lowering therapy); BMI
$25 kg/m2; family history of premature CHD.
A total of 7447 participants were randomised in a 1:1:1 ratio
to a parallel-design intervention trial of dietary advice: (1) a
MeDiet supplemented with extra-virgin olive oil; (2) a
MeDiet supplemented with nuts; (3) a low-fat diet (control
group). Medical conditions and risk factors related to eligibility
were collected using a questionnaire during the first screening
visit. Participants, with the assistance of trained dietitians,
completed an FFQ. This FFQ was adapted from the Willett
questionnaire and validated in Spain(28). It includes 137
items plus vitamin/mineral supplements, and specific ques-
tions for patterns of alcohol consumption. Energy and nutrient
intakes were calculated from Spanish food composition
tables(29). Participants also completed the Spanish validated
version of the Minnesota physical activity questionnaire(30),
and a fourteen-item dietary screener to assess the adherence
to the MeDiet(31). PREDIMED dietitians were responsible for
the accurate completion of the questionnaires.
For the present study, 133 participants were excluded from the
analyses because they reported values for total energy intake
outside of the predefined limits (,3347kJ (,800kcal)/d or
.17 573 kJ (.4200kcal)/d for men; ,2510 kJ (,600kcal)/d or
.14 644 kJ (.3500kcal)/d for women). These limits were set in
accordancewith those recommendedbyWillett inNutritional Epi-
demiology(32). Another seventy-eight participants were excluded
Dietary inflammatory index and obesity 985
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
because of lack of information on the FFQ needed to calculate
the DII. This study was registered as an International Standard
Randomised Controlled Trial, number ISRCTN35739639.
Dietary inflammatory index
The design and development of the DII has been described
elsewhere(25). Briefly, the DII is a scoring algorithm based
on an extensive review of the literature published from 1950
to 2010, linking 1943 articles to a total of forty-five food para-
meters and including various macronutrients, micronutrients,
flavonoids and food items (Fig. 1). These dietary parameters
were scored according to whether they increased (þ1),
decreased (21) or had no effect (0) on six inflammatory bio-
markers (IL-1b, IL-4, IL-6, IL-10, TNF-a and C-reactive protein
(CRP)). An overall food parameter-specific inflammatory effect
score was calculated and multiplied by a centred percentile
value for each food. This percentile was calculated by first
linking the dietary data from a study to the regionally repre-
sentative world database intake, which was based on actual
human consumption in eleven populations from different
parts of the world that provided a robust estimate of a mean
and standard deviation for each parameter. These values
then become the multipliers to express an individual’s
exposure, relative to the ‘standard global mean’ as a z-score.
This was achieved by subtracting the ‘standard global mean’
from the amount reported, and dividing this value by the stan-
dard deviation. To minimise the effect of ‘right skewing’, this
value was then converted to a centred percentile score. The
centred percentile score for each food parameter for each
individual was multiplied by the respective food parameter
effect score that was derived from the literature review
in order to obtain a food parameter-specific DII score for an
individual. All of the food parameter-specific DII scores
were then summed to create the overall DII score for every
participant in the study. The greater the DII score, the more
pro-inflammatory the diet, and more negative values represent
more anti-inflammatory diets. The DII score could take on
values ranging from 7·98 (maximally pro-inflammatory) to
28·87 (maximally anti-inflammatory)(25).
Construct validation of the DII was performed using
data derived from two different sources of dietary intake
information, and serum high-sensitivity CRP as the construct
validator(33).
Outcome
Trained and certified PREDIMED nurses performed all base-
line anthropometric adiposity measures including weight
and height (from which BMI (kg/m2) was computed), waist
circumference (cm) and WHtR (%) following validated pro-
cedures. A waist:height ratio equal to 1 was taken as 100 %.
Baseline weight was measured using a calibrated balance
beam scale with the subjects barefoot and wearing light
clothes. The nurse measured height using a wall-mounted cali-
brated stadiometer. Waist circumference was measured using
an anthropometric measuring tape, at a horizontal plane
midway between the lowest rib and the iliac crest.
Statistical analyses
Statistical analyses were stratified by sex. Comparisons of
quantitative variables across the quintiles of the DII were
made using a one-way ANOVA. The compared variables
included total energy intake, physical activity and nutrient
and food consumption. Intakes of carbohydrate, protein and
fat (and fat subtypes) are expressed as a percentage of total
energy intake (Table 1). Categorical variables were compared
using the Pearson x 2 test.
Sex-specific least-squared means of BMI, waist circum-
ference and WHtR were estimated across the quintiles of
the DII. Pearson’s correlation coefficients (95 % CI) between
these anthropometric adipose measures and the DII were
also calculated.
Sex-specific multiple linear regression models were used to
estimate the differences (and 95 % CI) in the indices of general
obesity and abdominal obesity according to the quintiles of
the DII. Covariates included in these models were age
(years), smoking status (never, current or former smoker),
diabetes (yes or no), hypertension (yes or no), leisure-time
physical activity (metabolic equivalents-min/d), educational
level (illiterate/elementary education, secondary education
or university), marital status (married, widowed, single or
other), total energy intake (kJ/d) and study centre. In addition,
tests of linear trend across the successive quintiles of the DII
were conducted using the median value for each quintile
category as a continuous variable, and after adjusting for the
aforementioned confounding variables.
Residuals of the DII were obtained in a linear regression
analysis of the association between the DII and a previously
validated fourteen-item PREDIMED screener of adherence
to the MeDiet(31). These residuals represent the information
provided by the DII, which is not explained at all by adher-
ence to the MeDiet (i.e. they exhibit zero correlation with
the MeDiet score). They were included as an independent
variable after transformation into quintiles in a multivariable
regression model with the same covariates listed previously
(residual model).
All P values presented are two-tailed, and differences
were considered statistically significant at P#0·05. All statis-
tical analyses were performed using STATAw version 12.0
(Stata Corp).
Results
Of the 7447 initially randomised subjects in the PREDIMED
trial, 7236 were included in the present study. The remaining
participants (n 211, 2·8 %) were excluded because of
incomplete data on their FFQ (n 78) or baseline energy
intake outside of the predefined values (n 133). Among the
7236 participants, 57 % were women. The mean age of the
participants was 68 (SD 5·8) years for women and 66 (SD 6·6)
years for men. The median DII score for women was 20·78
(24·90 to 3·68) and 20·91 (25·23 to 3·69) for men.
Table 1 shows the main characteristics of the participants
according to the categories of the DII score by sex. All differ-
ences between the quintiles of this index were statistically
M. Ruiz-Canela et al.986
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Review of articles published from 1950 to 2010, resulting in 1943 studies linking a total 
of forty-five food parameters with inflammatory biomarkers
+1 to each article if the effects were pro-inflammatory (significantly increased IL-1β, 
IL-6, TNF-α or CRP, or decreased IL-4 or IL-10), 
–1 if the effects were anti-inflammatory (significantly decreased IL-1β, IL-6, TNF-α or 
CRP, or increased IL-4 or IL-10), 
0 if the food parameter did not produce any significant change in the inflammatory
marker
The score for each food parameter was weighted according to the study design. 
The weights were 10 (experimental design), 8 (observational), 7 (case–control),
6 (cross-sectional), 5 (experimental with animals), 3 (cell culture) 
A food parameter-specific overall inflammatory effect score was calculated by 
substracting the anti-inflammatory fraction from the pro-inflammatory fraction. 
This score was corrected if the total weighted number of articles was <236. In these 
cases the raw overall inflammatory score is multiplied by the total weighted number of 
articles divided by 236
z-Score and centred percentiles for each of the thirty-three food parameters* for each
participant of the PREDIMED trial were calculated based on the average and standard
deviation for each food parameter obtained from the global database that was created
from the consumption of the original forty-five food parameters fron eleven countries
from around the world
The centred percentile for each food parameter is multiplied by the respective
‘overall food parameter-specific inflammatory effect score’ to obtain the ‘food
parameter-specific DII score’
Twelve food parameters were excluded 
because they could not be measured with 
the FFQ used in the PREDIMED trial
All of the ‘food parameter-specific DII scores’ are summed to create the ‘overall DII 
score’ for each individual
A score for each food parameter was calculated giving:
Fig. 1. Sequence of steps in creating the dietary inflammatory index in the PREvencio´n con DIeta MEDiterra´nea (PREDIMED) trial. *Alcohol, b-carotene, caffeine,
carbohydrate, cholesterol, energy, iron, fibre, folic acid, garlic, green/black tea, magnesium, MUFA, n-3 fatty acids, n-6 fatty acids, niacin, onion, pepper, protein,
PUFA, riboflavin, saturated fat, Se, thiamin, total fat, trans-fat, vitamin A, vitamin B12, vitamin B6, vitamin C, vitamin D, vitamin E and Zn. CRP, C-reactive protein;
DII, dietary inflammatory index. (A colour version of this figure can be found online at http://www.journals.cambridge.org/bjn).
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Table 1. Description of the main characteristics of the participants according to quintiles (Q) of the dietary inflammatory index (DII) score in the PREvencio´n con DIeta MEDiterra´nea (PREDIMED)
Trial, 2003–9
(Mean values and standard deviations; median values, minimum and maximum values, and percentages)
Quintiles of the DII
Women Men
Q1* Q2 Q3 Q4 Q5† P Q1* Q2 Q3 Q4 Q5† P
DII
Median 22·6 21·6 20·8 0·1 1·5 22·7 21·7 20·9 20·07 1·3
Minimum, maximum 24·9, 22 22, 21·2 21·2, 20·3 20·3, 0·7 0·7, 3·7 25·2, 22·2 22·2, 21·4 21·4, 20·5 20·5, 0,5 0·5, 3·7
n 829 829 829 829 829 619 618 618 618 618
Age (years) ,0·001 0·180
Mean 67 67 68 68 69 66 66 66 66 66
SD 6 6 6 6 6 6 6 7 7 7
Family history of early CHD (%) 27 28 27 26 24 0·362 21 18 17 16 15 0·039
Hypertension (%) 84 86 87 87 87 0·359 76 78 79 79 77 0·436
Dyslipidaemia (%) 79 79 76 75 74 0·016 71 66 66 65 63 0·033
Diabetes (%) 44 40 44 44 49 0·011 53 53 53 56 56 0·625
Smoking (%) 0·250 0·176
Current smoker 4 5 6 6 6 24 24 25 28 27
Former smoker 7 8 8 8 6 48 52 46 46 49
Total energy intake (kcal/d) ,0·001 ,0·001
Mean 2442 2281 2136 1990 1767 2769 2577 2412 2252 2038
SD 478 449 435 414 400 585 558 511 459 463
Total energy intake (kJ/d)
Mean 10 217 9544 8937 8326 7393 11 586 10 782 10 092 9422 8527
SD 2000 1879 1820 1732 1674 2448 2335 2138 1920 1937
Physical activity (MET-h/d) ,0·001 ,0·001
Mean 3·4 2·9 3·0 2·8 2·4 6·1 5·3 5·1 4·8 4·3
SD 3·2 2·8 2·8 2·7 2·4 6·0 4·7 4·9 4·4 3·9
Alcohol intake (g/d) 0·001 ,0·001
Mean 3·8 3·2 2·7 3·3 2·7 18·4 15·2 15·5 14·5 13·3
SD 7·6 6·1 5·1 6·1 5·7 18·1 17·5 19·0 18·2 17·9
Marital status (%) 0·004 0·043
Married 72 66 66 67 62 92 91 89 89 86
Widowed 20 27 27 26 30 3 3 3 3 6
Single/other 8 7 7 7 8 5 6 8 8 8
Educational level (%) ,0·001 0·066
Primary education or less 80 86 87 86 88 64 66 71 69 67
Secondary education 13 11 9 11 9 21 23 19 22 22
Any college 7 3 4 3 3 15 12 11 10 11
MET, metabolic equivalents.
* Highest anti-inflammatory values of the DII.
† Highest pro-inflammatory values of the DII.
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Table 2. Nutrient and food consumption according to quintiles (Q) of the dietary inflammatory index (DII) in the PREvencio´n con DIeta MEDiterra´nea (PREDIMED) trial, 2003–9
(Mean values and standard deviations)
Quintiles of the DII
Women Men
Q1* Q2–Q4 Q5† Q1* Q2–Q4 Q5†
Mean SD Mean SD Mean SD P Mean SD Mean SD Mean SD P
Carbohydrate intake (%E) 43·4 7·0 42·6 6·7 40·8 6·8 ,0·001 41·2 7·0 41·5 7·3 39·2 7·8 ,0·001
Protein intake (%E) 17·2 2·6 17·1 2·7 17·2 3·1 0·452 16·0 2·6 15·9 2·7 16·0 2·8 0·542
Vegetal protein intake (%E) 6·1 1·1 5·4 1·0 4·9 1·0 ,0·001 5·8 1·1 5·4 1·0 4·9 1·0 ,0·001
Animal protein intake (%E) 11·1 2·7 11·6 2·8 12·3 3·2 ,0·001 10·2 2·7 10·5 2·8 11·1 2·9 ,0·001
Total fat intake (%E) 38·4 6·8 39·4 6·6 40·9 6·9 ,0·001 38·2 6·5 38·5 6·7 40·4 7·2 ,0·001
Saturated fat (%E) 9·2 2·0 10·0 2·1 10·8 2·4 ,0·001 9·3 2·1 9·9 2·2 10·8 2·4 ,0·001
Monounsaturated fat (%E) 18·2 4·5 19·7 4·5 21·0 4·8 ,0·001 18·3 4·2 19·2 4·4 20·9 4·6 ,0·001
Polyunsaturated fat (%E) 7·2 2·2 6·2 2·1 5·6 1·7 ,0·001 7·1 2·2 6·2 2·0 5·6 1·6 ,0·001
Alcohol consumption (g/d) 3·8 7·4 3·0 5·8 2·8 5·8 0·002 18·5 18·1 15·0 18·2 13·4 17·8 ,0·001
Fibre (g/d) 34·6 9·3 24·7 6·1 16·1 3·6 ,0·001 34·4 8·8 25·8 6·5 17·1 3·8 ,0·001
Vitamin E (mg/d) 12·5 3·7 9·7 3·7 7·0 2·6 ,0·001 13·4 4·8 10·5 4·0 7·5 2·5 ,0·001
Vitamin C (mg/d) 289 99 201 70 123 42 ,0·001 271 98 195 72 122 44 ,0·001
Vitamin A (mg/d) 1757 784 1235 640 847 485 ,0·001 1870 907 1325 1095 849 500 ,0·001
Vegetables (g/d) 483 168 327 107 213 78 ,0·001 482 179 324 111 212 80 ,0·001
Fruits (g/d) 487 214 379 186 231 118 ,0·001 462 231 377 195 237 138 ,0·001
Cereals (g/d) 143 78 132 76 111 63 ,0·001 175 96 165 95 138 86 ,0·001
Potatoes (g/d) 96 58 80 48 62 39 ,0·001 102 58 86 46 70 40 ,0·001
Legumes (g/d) 25·8 16·8 19·7 12·9 14·8 7·8 ,0·001 26·2 15·1 21·5 14·0 16·3 8·4 ,0·001
Nuts (g/d) 18·6 18·4 8·2 10·8 3·3 5·6 ,0·001 20·6 19·6 10·3 12·9 4·9 8·1 ,0·001
Fish and seafoods (g/d) 123·9 60·6 95·2 41·7 74·8 36·5 ,0·001 130·7 56·2 101·0 53·8 79·7 39·3 ,0·001
Meat and meat products (g/d) 125·0 57·3 127·2 50·9 114·5 49·1 ,0·001 144·7 68·8 141·1 58·3 136·0 61·9 0·044
Dairy products (g/d) 435·5 238·4 408·1 221·0 381·4 218·9 ,0·001 369·1 222·4 342·4 204·7 319 205·9 ,0·001
Mediterranean diet score (0–14) 9·5 1·9 8·6 1·8 7·7 1·7 ,0·001 9·8 1·9 8·7 1·9 8·0 1·7 ,0·001
%E, percentage of energy.
* Highest anti-inflammatory values of the DII.
† Highest pro-inflammatory values of the DII.
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significant among women, except for the percentage of
subjects with a family history of early CHD, the presence of
hypertension and smoking status. Among men, differences
between the quintiles of the DII according to age, hyper-
tension, diabetes and smoking status were not statistically
significant. In both sexes, the level of physical activity was
inversely associated with the DII, as was total energy intake
and alcohol intake.
All macro- and micronutrient intakes were higher in the
quintile with the lowest DII score (anti-inflammatory dietary
pattern), except for intakes of animal protein, saturated fat
and monounsaturated fat, both among women and men
(Table 2). Better adherence to a MeDiet also was associated
with lower DII scores.
Table 3 shows the adjusted indices of obesity based on BMI,
waist circumference and WHtR, according to the DII score
stratified by sex. The lower and upper limits of this score
are shown for each quintile. Mean values of all three adiposity
indices increased linearly across the successive quintiles of DII
scores (from anti-inflammatory to pro-inflammatory levels).
A significant positive correlation was observed between
these obesity indices and the DII score.
Among women, the DII was directly associated with
BMI, after adjusting for multiple factors related to obesity
(Table 4). Being in the highest quintile of the DII was associ-
ated with an increase in BMI of 0·79 kg/m2 (95 % CI 0·35, 1·23)
compared with the lowest quintile (P for trend¼0·001). This
association was not statistically significant for men.
Table 4 further shows that waist circumference and WHtR
increased progressively across quintiles 2–4 and 5 compared
with the lowest quintile of the DII, both in women and men
(P for trend being statistically significant in all comparisons).
Table 5 shows the association of the DII with the anthro-
pometric indices, after considering the possible contribution
of the MeDiet elements to the anti- or pro-inflammatory
capacity of the diet. A higher pro-inflammatory level of the
diet (beyond the effect of lower adherence to the MeDiet)
was associated with higher adjusted means of BMI, waist
circumference and WHtR (P for trend ,0·05 in all compari-
sons except for BMI among men). The predicted increase
in anthropometric measures was statistically significant in
women, except for the increase in BMI and WHtR, when the
intermediate DII quintiles (2–4) were compared with the
lowest category. On the contrary, the results were not statisti-
cally significant among men, except for waist circumference
and WHtR, when comparing the highest v. the lowest quintile
of the residuals of the DII.
Discussion
In the present study, we used the dietary inflammatory index
(DII) score to assess the capacity of the overall dietary pattern
to promote inflammation. Higher values of the DII represent
a higher inflammatory potential of the diet. As expected, we
observed that the DII was inversely associated with the
intake of healthy foods, nutrients and adherence to the
MeDiet. A pro-inflammatory DII was directly associated with
the indices of general and abdominal obesity, independent T
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of established risk factors for obesity including total energy
intake, age, smoking status, diabetes, hypertension, physical
activity, educational level and marital status. These results
were consistent for both sexes except for BMI in men. In
the residual model (after removing the variability explained
by the MeDiet), the association between the inflammatory
potential of the diet and higher adiposity indices remained
apparent; however, there was a clear association between
the DII and the abdominal indices of obesity for women com-
pared with men.
The associations observed between nutrient intake or food
consumption and the DII are consistent with previous
research. Several studies have shown an inverse association
between healthy diets and markers of inflammation, as well
as a direct association with ‘Western-like’ dietary pat-
terns(8–14). Specifically, a lower CRP concentration has been
associated with a higher intake of fruits and vegetables(34–36),
legumes(37), nuts(38), and low-fat dairy consumption(39).
Previous studies have also observed associations of specific
nutrients such as total dietary fibre intake(40), moderate
alcohol consumption(41), and vitamin E and vitamin C
intake(42) with lower levels of inflammation markers. On the
contrary, animal protein seems to increase the inflammatory
status of obese individuals(43).
We also found that a higher consumption of dairy products
and meat (or meat products) was less frequent in the highest
DII quintile. A systematic review has found no impact of
dairy product consumption on biomarkers of inflammation
in overweight and obese adults(44). However, only one out
of eight trials included in this review defined inflammation
as its primary outcome, and there were some methodological
limitations in them such as insufficient statistical power(44).
Concerning the consumption of meat, a cross-sectional ana-
lysis of data from 3690 diabetes-free female participants
found that a higher intake of meat protein was associated
with higher plasma levels of inflammatory markers(45). How-
ever, a cross-sectional study has shown that the association
between red meat intake and inflammatory markers was no
Table 4. Multivariable-adjusted* differences in the indices of general obesity and abdominal obesity according to quintiles (Q) of the dietary inflamma-
tory index in the PREvencio´n con DIeta MEDiterra´nea (PREDIMED) trial, 2003–9
(Adjusted differences and 95 % confidence intervals)
Quintiles of the dietary inflammatory index
Q1 (highest anti-inflamma-
tory) Q2–Q4 Q5 (highest pro-inflammatory)
Adjusted
difference 95 % CI
Adjusted
difference 95 % CI
Adjusted
difference 95 % CI P for trend
Women
BMI (kg/m2)* 0 Reference 0·56 0·23, 0·89 0·79 0·35, 1·23 0·001
Waist circumference (cm)* 0 Reference 2·03 1·17, 2·90 2·79 1·64, 3·93 ,0·001
Waist:height ratio (%)*† 0 Reference 1·19 0·64, 1·74 1·60 0·87, 2·33 ,0·001
Men
BMI (kg/m2)* 0 Reference 0·05 20·26, 0·37 0·33 20·08, 0·74 0·100
Waist circumference (cm)* 0 Reference 0·98 0·07, 1·89 1·74 0·53, 2·94 0·005
Waist:height ratio (%)*† 0 Reference 0·44 20·09, 0·97 1·04 0·35, 1·74 0·003
* Adjusted for age, smoking status, diabetes, hypertensive, physical activity, total energy intake, educational level, marital status and study centre.
† A waist:height ratio equal to 1 was taken as 100 %.
Table 5. Multivariable-adjusted* differences in the indices of general obesity and abdominal obesity according to adherence to the residuals of the
dietary inflammatory index on the fourteen-item PREvencio´n con DIeta MEDiterra´nea (PREDIMED) score of adherence to the Mediterranean diet in the
PREDIMED trial 2003–9
(Adjusted differences and 95 % confidence intervals)
Quintiles of the dietary inflammatory index (adjusted for adherence to the Mediterranean diet)
Q1 (highest
anti-inflammatory) Q2–Q4
Q5 (highest
pro-inflammatory)
Adjusted
difference 95 % CI
Adjusted
difference 95 % CI
Adjusted
difference 95 % CI P for trend*
Women
BMI (kg/m2)* 0 Reference 0·14 20·19, 0·48 0·36 20·08, 0·80 0·041
Waist circumference (cm)* 0 Reference 1·01 0·14, 2·81 1·67 0·52, 2·82 ,0·001
Waist:height ratio (%)*† 0 Reference 0·34 20·20, 0·91 0·76 0·04, 1·49 0·007
Men
BMI (kg/m2)* 0 Reference 0·06 20·26, 0·36 0·31 20·10, 0·73 0·057
Waist circumference (cm)* 0 Reference 0·77 20·14, 1·69 1·46 0·24, 2·68 0·004
Waist:height ratio (%)*† 0 Reference 0·44 20·09, 0·96 0·96 0·26, 1·67 0·005
* Adjusted for age, smoking status, diabetes status, hypertensive status, physical activity, energy intake, educational level, marital status and study centre.
† A waist:height ratio equal to 1 was taken as 100 %.
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longer observed after adjustment for BMI(46). Therefore, it is
suggested that the association between red meat intake and
inflammation is probably mediated by obesity.
In the present study, a higher pro-inflammatory diet was
observed in participants with higher BMI, waist circumference
and WHtR. This result suggests the hypothesis that a diet-
induced inflammation might contribute to increasing or main-
taining obesity, especially abdominal obesity, in a population
that is mostly overweight or obese. The origin of inflammation
during obesity is not yet fully understood. It is acknowledged
that inflammation is induced by adiposity(4,5), but this relation-
ship can be bidirectional (i.e. a pro-inflammatory diet
can increase or maintain adiposity), thus creating a vicious
cycle, because nutrient excess and some specific foods or
nutrients also have been associated with inflammation(47).
The potential mechanisms underlying this association is the
activation of pathogen-associated molecular patterns, such as
Toll-like receptors and Nod-like receptors, which induce the
activation of inflammatory markers in several tissues including
the adipose tissue(48). Moreover, dietary patterns (e.g. high-
fat/low-fibre or low-fat/high-fibre diet) and single specific
nutrients (e.g. dietary fibre) appear to have important con-
sequences in the gut microbiota, which is also involved in
low-grade inflammation associated with obesity(49–52).
The residuals of the DII (from a regression model on adher-
ence to the MeDiet) were also associated with obesity indices.
These residuals represent the information provided by the
DII about the anti- or pro-inflammatory capacity of a diet,
which could not be explained by adherence to the MeDiet.
The most pro-inflammatory diet showed a stronger association
with waist circumference than with other anthropometric
indices, both among women and men. These results are in
close agreement with previous findings, which showed that
central adiposity-related indices are more strongly correlated
with plasma pro-inflammatory markers than indices assessing
total adiposity in healthy young adults(5). Moreover, abdomi-
nal adiposity has been associated with elevated CRP levels,
independent of BMI in older adults(53). As a consequence,
the present results reinforce the usefulness of the DII to
assess the inflammatory properties of a diet, and the associ-
ation between inflammation and central obesity indices.
The present results are also consistent with those of studies
reporting a stronger association between CRP and BMI in
women than in men(54,55). This between-sex difference
could be partially explained by a greater accumulation of
subcutaneous fat in women than in men, and higher lean
mass in men(55). Sex differences in the metabolic activity of
adipose tissue, as well as in the association between leptin
and CRP, may also explain these differences(56,57).
The strengths of the present study include the following:
large sample size; use of a validated instrument to measure
the inflammatory potential of the diet; adjustment for a
large number of factors associated with obesity; detailed
measures of obesity indices; validation of all assessment
instruments including the MeDiet screener, the FFQ and the
physical activity questionnaire. The present study also has
its limitations, the main one being the cross-sectional nature
of our analyses. It is, therefore, unclear whether obese
individuals are more likely to choose pro-inflammatory diets,
or if pro-inflammatory diets contribute to promoting or main-
taining obesity. Both weight reduction and an overall healthy
dietary pattern have the capacity to reduce inflammatory
markers. Thus, the association between the DII and obesity
indices remains to be confirmed in prospective analyses.
Another limitation is that anthropometric measures are surro-
gate markers of abdominal obesity. Waist circumference and
WHtR do not differentiate between visceral adipose tissue
and subcutaneous abdominal adipose tissue(58). Therefore,
we cannot determine whether the DII is more strongly associ-
ated with visceral, subcutaneous or both types of abdominal
fat mass. Finally, the DII is limited by the existing knowledge
of the inflammatory factors involved in obesity. However, the
DII has been found to be associated with the following factors:
inflammatory cytokines including CRP and IL-6(33,59,60);
glucose intolerance component of the metabolic syndrome(59);
odds of asthma and of reduced FEV1 (forced expiratory
volume in 1 s) in an Australian population(60). It has also
been reportedly associated with a higher risk of colorectal
cancer(61), prostate cancer(62) and pancreatic cancer(63).
In conclusion, the present findings indicate an association
between anti-inflammatory values of the DII and intake of
healthy foods and nutrients and higher adherence to the
MeDiet. A pro-inflammatory diet is associated with elevated
indices of central and abdominal obesity. This association
suggests that the DII may have the capacity to help elucidate
the role that diet plays in the development of obesity through
inflammatory processes.
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